LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
Clinical trials for LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for bladder cancer: experimental drug joins standard combo
Disease control Recruiting nowThis study tests whether adding an experimental drug (MK-3120) to the standard treatment (enfortumab vedotin plus pembrolizumab) is safe and effective for people with advanced bladder cancer that has spread. About 55 participants will receive the new combination. Researchers will…
Matched conditions: LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could less chemo mean better quality of life for bladder cancer patients?
Disease control Recruiting nowThis study compares 3 versus 6 cycles of platinum-based chemotherapy followed by the immunotherapy drug avelumab in 320 people with advanced bladder cancer. The goal is to see if fewer chemo cycles improve quality of life without harming cancer control. Participants receive eithe…
Matched conditions: LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New bladder cancer cocktail aims to outdo chemo
Disease control Recruiting nowThis phase 3 trial is testing whether a combination of two drugs, SHR-A2102 and adebrelimab, works better than standard chemotherapy for people with advanced bladder cancer that has not been treated before. About 462 participants will be randomly assigned to receive either the ne…
Matched conditions: LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
Phase: PHASE3 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug BL-B01D1 targets Hard-to-Treat solid tumors in early trial
Disease control Recruiting nowThis Phase II trial is testing a drug called BL-B01D1 in 76 adults with advanced urinary system or other solid tumors that have not responded to standard treatments. The study aims to find the best dose and see how well the drug shrinks tumors, while also monitoring safety and si…
Matched conditions: LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC